4//SEC Filing
ACCENTIA BIOPHARMACEUTICALS INC 4
Accession 0001181431-10-057910
CIK 0001310094operating
Filed
Nov 28, 7:00 PM ET
Accepted
Nov 29, 4:58 PM ET
Size
5.1 KB
Accession
0001181431-10-057910
Insider Transaction Report
Form 4
Pearce Alan M
DirectorChief Financial Officer
Transactions
- Award
Common Stock
2010-11-24+750,000→ 987,507 total
Footnotes (1)
- [F1]Restricted stock grant acquired pursuant to the Issuer's plan of compensation for Employees. The restricted stock grant was effective and immediately vested upon effective date of the Issuer's Bankruptcy Plan of Reorganization and the closing of a capital raise by the Issuer's with gross proceeds of a minimum of $5.0 million.
Documents
Issuer
ACCENTIA BIOPHARMACEUTICALS INC
CIK 0001310094
Entity typeoperating
IncorporatedFL
Related Parties
1- filerCIK 0001310094
Filing Metadata
- Form type
- 4
- Filed
- Nov 28, 7:00 PM ET
- Accepted
- Nov 29, 4:58 PM ET
- Size
- 5.1 KB